CD274 and neoplasm: The catalase and photosensitizer-loaded hybrid nanoparticles show enhanced retention in tumor tissue, leading to greatly relieved tumor hypoxia via decomposition of tumor endogenous H2O2 and improving anti-PD-L1 checkpoint blockade therapy [28].